What is the Zim Laboratories Ltd share price today?

The share price of NSE:ZIMLAB-EQ on 01 Oct 2026 (as of 15:05:18 IST) is ₹134.36.

What is the NSE:ZIMLAB-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:ZIMLAB-EQ 52 week high low range shows a high of ₹144.49 and a low of ₹59.31.

What is the Zim Laboratories Ltd market cap?

As on 01 Oct 2026, Zim Laboratories Ltd market cap is ₹7402190000.

What is the shareholding pattern of Zim Laboratories Ltd Stock?

The shareholding pattern of Zim Laboratories Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 30.36% Foreign Institutional Investors (FII): 0.03% Domestic Institutional Investors (DII): 0.27% Mutual Funds: 1.07% Retail & Others: 68.27% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Zim Laboratories Ltd?

The Price-to-Earnings (PE) ratio of Zim Laboratories Ltd is 200.276, and the Price-to-Book (PB) ratio is 1.0905, as on 01 Oct 2026.

Zim Laboratories Share Price

144.76+4.46 (+3.18%)

+109.49% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+3.18%

1 Week

-5.16%

1 Month

+4.96%

3 Month

+19.64%

6 Month

+81.61%

YTD

+100.64%

1 Year

+109.49%

5 Year

10 Year

Max

+29.25%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

138.50

130.20

106.00

78.92

59.31

High

148.00

153.93

159.81

About

ZIM Laboratories is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these within and outside India. The company has a comprehensive Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

LAURUSLABSNSE

CIPLANSE

DRREDDYNSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

ZIMLABNSE

LTP

1W Low

1W High

Market cap (₹)

1758.8-1.2 (-0.07%)

1725.50

1778

4,22,427Cr

9144.5-281.5 (-2.99%)

8937.50

9431.50

2,39,982Cr

4558.9-123.1 (-2.63%)

4550.40

4682

1,75,196Cr

1123-11.4 (-1.00%)

1107.30

1150.90

1,13,790Cr

2060.1-9.1 (-0.44%)

2007.80

2086

1,09,143Cr

1325.1+13.8 (1.05%)

1300.20

1337.50

1,07,746Cr

1233+3.6 (0.29%)

1196.90

1250.70

1,01,894Cr

2275.5-124.5 (-5.19%)

2268.70

2426.80

97,264Cr

1666.9-40 (-2.34%)

1647.10

1715

96,376Cr

1961.6+26.6 (1.37%)

1925.70

1990.90

89,592Cr

144.76-7.87 (-5.16%)

138.50

159.81

751Cr

Zim Laboratories Share Price

144.76+4.46 (+3.18%)

+109.49% past 1 Year

Open a free Demat account in minutes to start investing and screening .

Zim Laboratories Share Price

144.76+4.46 (+3.18%)

+109.49% past 1 Year

Financial overview

Compounded Sales Growth

10 years3%

5 years4%

3 years-2%

Last year-1%

Compounded Profit Growth

10 years1%

5 years-4%

3 years-38%

Last year-52%

Stock Price CAGR

10 years-

5 years-

3 years6%

1 year112%

Return on Equity

10 years9%

5 years7%

3 years5%

Last year2%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
3%	4%	-2%	-1%
1%	-4%	-38%	-52%
-	-	6%	112%
9%	7%	5%	2%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

LAURUSLABS

CIPLA

DRREDDY

MANKIND

AUROPHARMA

LUPIN

ZIMLAB

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,758.8	₹422427 Cr	34.92	12.07	62.82	₹11479 Cr
9,144.5	₹239982 Cr	82.05	34.04	128.41	₹2568 Cr
4,558.9	₹175196 Cr	80.33	16.72	97.06	₹2163 Cr
1,123	₹113790 Cr	25.21	9.42	62.53	₹5040 Cr
2,060.1	₹109143 Cr	99.82	6.8	29.25	₹889 Cr
1,325.1	₹107746 Cr	31.97	9.77	57.87	₹3879 Cr
1,233	₹101894 Cr	31.62	5.32	63.99	₹4196 Cr
2,275.5	₹97264 Cr	47.62	13.75	71.08	₹1913 Cr
1,666.9	₹96376 Cr	25.96	17.95	96.84	₹3505 Cr
1,961.6	₹89592 Cr	16.2	30.95	154.35	₹5333 Cr
144.76	₹751 Cr	203.18	-0.75	4.51	₹6 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017
₹94 Cr	₹105 Cr	₹109 Cr	₹89 Cr	₹72 Cr	₹109 Cr	₹96 Cr	₹92 Cr	₹82 Cr	₹118 Cr	₹96 Cr	₹86 Cr	₹67 Cr	₹105 Cr	₹101 Cr	₹99 Cr	₹93 Cr	₹105 Cr	₹87 Cr	₹77 Cr	₹64 Cr	₹74 Cr	₹75 Cr	₹88 Cr	₹70 Cr	₹69 Cr	₹73 Cr	₹68 Cr	₹67 Cr	₹95 Cr	₹98 Cr	₹72 Cr	₹71 Cr	₹72 Cr	₹75 Cr	₹63 Cr	₹65 Cr
₹99 L	₹6 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹100 L	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹69 L	₹2 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹68 L	₹87 L	₹1 Cr	₹83 L	₹70 L	₹19 L	₹62 L	₹2 Cr	₹62 L	₹42 L	₹1 Cr	₹80 L	₹72 L	₹19 L	₹1 Cr	₹2 Cr	₹26 L	₹1 Cr	₹26 L
₹95 Cr	₹111 Cr	₹110 Cr	₹91 Cr	₹73 Cr	₹110 Cr	₹98 Cr	₹93 Cr	₹83 Cr	₹119 Cr	₹97 Cr	₹87 Cr	₹69 Cr	₹106 Cr	₹103 Cr	₹101 Cr	₹95 Cr	₹107 Cr	₹87 Cr	₹78 Cr	₹65 Cr	₹75 Cr	₹76 Cr	₹88 Cr	₹71 Cr	₹72 Cr	₹74 Cr	₹68 Cr	₹68 Cr	₹95 Cr	₹99 Cr	₹72 Cr	₹72 Cr	₹73 Cr	₹75 Cr	₹64 Cr	₹65 Cr
₹97 Cr	₹103 Cr	₹101 Cr	₹88 Cr	₹72 Cr	₹99 Cr	₹90 Cr	₹88 Cr	₹79 Cr	₹106 Cr	₹89 Cr	₹81 Cr	₹67 Cr	₹95 Cr	₹92 Cr	₹92 Cr	₹86 Cr	₹94 Cr	₹80 Cr	₹72 Cr	₹63 Cr	₹69 Cr	₹71 Cr	₹79 Cr	₹64 Cr	₹66 Cr	₹69 Cr	₹67 Cr	₹68 Cr	₹88 Cr	₹88 Cr	₹64 Cr	₹65 Cr	₹65 Cr	₹67 Cr	₹57 Cr	₹60 Cr
₹3 Cr	₹13 Cr	₹15 Cr	₹8 Cr	₹6 Cr	₹16 Cr	₹13 Cr	₹11 Cr	₹9 Cr	₹17 Cr	₹13 Cr	₹11 Cr	₹6 Cr	₹16 Cr	₹15 Cr	₹14 Cr	₹13 Cr	₹16 Cr	₹11 Cr	₹11 Cr	₹6 Cr	₹10 Cr	₹8 Cr	₹13 Cr	₹11 Cr	₹9 Cr	₹9 Cr	₹5 Cr	₹4 Cr	₹11 Cr	₹13 Cr	₹11 Cr	₹10 Cr	₹11 Cr	₹11 Cr	₹9 Cr	₹7 Cr
₹4 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹2 Cr
-₹6 Cr	₹5 Cr	₹6 Cr	-₹34 L	-₹2 Cr	₹8 Cr	₹6 Cr	₹3 Cr	₹1 Cr	₹11 Cr	₹7 Cr	₹5 Cr	₹19 L	₹10 Cr	₹10 Cr	₹8 Cr	₹7 Cr	₹11 Cr	₹6 Cr	₹4 Cr	₹29 L	₹3 Cr	₹2 Cr	₹1 Cr	₹4 Cr	₹2 Cr	₹2 Cr	-₹2 Cr	-₹2 Cr	₹5 Cr	₹8 Cr	₹5 Cr	₹4 Cr	₹11 Cr	₹7 Cr	₹4 Cr	₹3 Cr
-₹4 Cr	₹4 Cr	₹4 Cr	-₹42 L	-₹2 Cr	₹5 Cr	₹4 Cr	₹2 Cr	₹90 L	₹8 Cr	₹5 Cr	₹4 Cr	₹23 L	₹7 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹7 Cr	₹4 Cr	₹3 Cr	₹19 L	₹2 Cr	₹1 Cr	₹1 Cr	₹3 Cr	₹2 Cr	₹2 Cr	-₹61 L	₹9 L	₹2 Cr	₹6 Cr	₹3 Cr	₹4 Cr	₹8 Cr	₹6 Cr	₹3 Cr	₹2 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
—	—	—	—	—	—	—	—	—	—	—	—
₹54 Cr	₹49 Cr	₹49 Cr	₹49 Cr	₹16 Cr	₹16 Cr	₹16 Cr	₹16 Cr	₹8 Cr	₹8 Cr	₹8 Cr	₹8 Cr
₹2 Cr	₹1 Cr	₹0	₹0	₹0	₹0	₹36 L	₹1 Cr	₹59 L	₹71 L	₹63 L	₹0
₹240 Cr	₹202 Cr	₹190 Cr	₹152 Cr	₹159 Cr	₹145 Cr	₹137 Cr	₹134 Cr	₹128 Cr	₹110 Cr	₹90 Cr	₹86 Cr
₹240 Cr	₹202 Cr	₹190 Cr	₹152 Cr	₹159 Cr	₹145 Cr	₹137 Cr	₹134 Cr	₹128 Cr	₹110 Cr	₹90 Cr	₹86 Cr
₹296 Cr	₹252 Cr	₹239 Cr	₹200 Cr	₹176 Cr	₹161 Cr	₹154 Cr	₹151 Cr	₹137 Cr	₹118 Cr	₹99 Cr	₹94 Cr
₹5,000	₹5,000	₹3,000	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹42 Cr	₹40 Cr	₹36 Cr	₹25 Cr	₹19 Cr	₹22 Cr	₹27 Cr	₹19 Cr	₹16 Cr	₹27 Cr	₹34 Cr	₹37 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹41 L	₹3 Cr	₹4 Cr	₹77 L	₹77 L	₹82 L
₹10 Cr	₹11 Cr	₹10 Cr	₹5 Cr	₹36 L	-₹3 Cr	-₹5 Cr	-₹2 Cr	-₹4 Cr	-₹9 Cr	₹0	₹0
₹83 L	₹2 Cr	₹3 Cr	₹1 Cr	₹72 L	₹17 L	₹63 L	₹0	₹0	₹0	₹0	₹0
₹0	₹0	₹0	₹0	₹0	₹1 L	₹0	₹10 L	₹0	₹0	₹0	₹0
₹52 Cr	₹53 Cr	₹49 Cr	₹30 Cr	₹20 Cr	₹19 Cr	₹23 Cr	₹20 Cr	₹17 Cr	₹18 Cr	₹35 Cr	₹38 Cr
—	—	—	—	—	—	—	—	—	—	—	—
₹73 Cr	₹70 Cr	₹62 Cr	₹58 Cr	₹81 Cr	₹65 Cr	₹66 Cr	₹72 Cr	₹66 Cr	₹45 Cr	₹47 Cr	₹64 Cr
₹52 Cr	₹41 Cr	₹41 Cr	₹29 Cr	₹45 Cr	₹31 Cr	₹27 Cr	₹39 Cr	₹25 Cr	₹18 Cr	₹17 Cr	₹17 Cr
₹62 Cr	₹52 Cr	₹55 Cr	₹23 Cr	₹17 Cr	₹45 Cr	₹50 Cr	₹40 Cr	₹50 Cr	₹47 Cr	₹56 Cr	₹51 Cr
₹4 Cr	₹5 Cr	₹80 L	₹59 L	₹4 Cr	₹1 Cr	₹1 Cr	₹6 Cr	₹43 L	₹3 Cr	₹4 Cr	₹2 Cr
₹191 Cr	₹168 Cr	₹159 Cr	₹111 Cr	₹147 Cr	₹142 Cr	₹143 Cr	₹156 Cr	₹141 Cr	₹113 Cr	₹124 Cr	₹134 Cr
₹540 Cr	₹473 Cr	₹447 Cr	₹342 Cr	₹343 Cr	₹322 Cr	₹320 Cr	₹328 Cr	₹295 Cr	₹250 Cr	₹257 Cr	₹266 Cr
₹10 Cr	₹5 Cr	₹6 Cr	₹7 Cr	₹7 Cr	₹6 Cr	₹6 Cr	₹5 Cr	₹6 Cr	₹6 Cr	₹4 Cr	₹3 Cr
₹123 Cr	₹112 Cr	₹106 Cr	₹59 Cr	₹51 Cr	₹81 Cr	₹90 Cr	₹77 Cr	₹81 Cr	₹81 Cr	₹96 Cr	₹93 Cr
—	—	—	—	—	—	—	—	—	—	—	—
₹290 Cr	₹275 Cr	₹267 Cr	₹199 Cr	₹180 Cr	₹165 Cr	₹159 Cr	₹136 Cr	₹113 Cr	₹98 Cr	₹120 Cr	₹108 Cr
₹128 Cr	₹111 Cr	₹106 Cr	₹90 Cr	₹75 Cr	₹59 Cr	₹43 Cr	₹30 Cr	₹19 Cr	₹9 Cr	₹28 Cr	₹20 Cr
₹162 Cr	₹164 Cr	₹161 Cr	₹109 Cr	₹106 Cr	₹107 Cr	₹116 Cr	₹106 Cr	₹94 Cr	₹89 Cr	₹92 Cr	₹87 Cr
₹59 Cr	₹44 Cr	₹24 Cr	₹18 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹8 Cr	₹5 Cr	₹3 Cr	₹3 Cr	₹6 Cr
₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L
₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L	₹5 L
₹5 Cr	₹5 Cr	₹16 Cr	₹14 Cr	₹12 Cr	₹11 Cr	₹10 Cr	₹12 Cr	₹18 Cr	₹3 Cr	₹6 Cr	₹4 Cr
₹29 L	₹51 L	₹31 L	₹52 L	₹28 L	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹16 L	₹48 L	₹28 L
₹263 Cr	₹241 Cr	₹219 Cr	₹151 Cr	₹129 Cr	₹130 Cr	₹138 Cr	₹132 Cr	₹122 Cr	₹96 Cr	₹102 Cr	₹97 Cr
—	—	—	—	—	—	—	—	—	—	—	—
₹94 Cr	₹86 Cr	₹81 Cr	₹54 Cr	₹75 Cr	₹54 Cr	₹56 Cr	₹55 Cr	₹52 Cr	₹35 Cr	₹38 Cr	₹46 Cr
₹109 Cr	₹107 Cr	₹100 Cr	₹95 Cr	₹90 Cr	₹72 Cr	₹68 Cr	₹93 Cr	₹89 Cr	₹88 Cr	₹89 Cr	₹81 Cr
₹43 Cr	₹2 Cr	₹10 Cr	₹8 Cr	₹5 Cr	₹8 Cr	₹4 Cr	₹3 Cr	₹4 Cr	₹6 Cr	₹6 Cr	₹8 Cr
₹3 Cr	₹3 Cr	₹2 Cr	₹3 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹1 Cr	₹47 L
₹27 Cr	₹34 Cr	₹33 Cr	₹32 Cr	₹42 Cr	₹55 Cr	₹52 Cr	₹43 Cr	₹28 Cr	₹24 Cr	₹21 Cr	₹34 Cr
₹277 Cr	₹232 Cr	₹228 Cr	₹191 Cr	₹214 Cr	₹192 Cr	₹182 Cr	₹195 Cr	₹173 Cr	₹154 Cr	₹155 Cr	₹169 Cr
₹85 Cr	₹65 Cr	₹68 Cr	₹80 Cr	₹66 Cr	₹50 Cr	₹39 Cr	₹39 Cr	₹32 Cr	₹41 Cr	₹32 Cr	₹35 Cr
₹540 Cr	₹473 Cr	₹447 Cr	₹342 Cr	₹343 Cr	₹322 Cr	₹320 Cr	₹328 Cr	₹295 Cr	₹250 Cr	₹257 Cr	₹266 Cr
₹55	₹51	₹49	₹41	₹108	₹99	₹95	₹93	₹169	₹146	₹123	₹118
₹55	₹51	₹49	₹41	₹36	₹33	₹32	₹31	₹28	₹24	₹20	₹20

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
₹8 Cr	₹18 Cr	₹24 Cr	₹35 Cr	₹21 Cr	₹15 Cr	₹7 L	₹22 Cr	₹25 Cr	₹17 Cr	₹5 Cr	-₹27 Cr
₹29 Cr	₹34 Cr	₹22 Cr	₹22 Cr	₹22 Cr	₹26 Cr	₹26 Cr	₹24 Cr	₹13 Cr	₹21 Cr	₹29 Cr	₹51 Cr
₹16 Cr	-₹12 Cr	-₹27 Cr	-₹12 Cr	₹7 Cr	-₹8 Cr	₹56 L	-₹10 Cr	₹3 Cr	-₹4 Cr	-₹11 Cr	-₹17 Cr
₹53 Cr	₹40 Cr	₹19 Cr	₹45 Cr	₹50 Cr	₹33 Cr	₹27 Cr	₹36 Cr	₹41 Cr	₹35 Cr	₹23 Cr	₹8 Cr
₹50 Cr	₹41 Cr	₹16 Cr	₹38 Cr	₹49 Cr	₹32 Cr	₹22 Cr	₹35 Cr	₹37 Cr	₹32 Cr	₹22 Cr	₹6 Cr
-₹56 Cr	-₹40 Cr	-₹73 Cr	-₹36 Cr	-₹15 Cr	-₹6 Cr	-₹19 Cr	-₹21 Cr	-₹26 Cr	-₹7 Cr	-₹12 Cr	-₹9 Cr
₹28 Cr	-₹9 Cr	₹60 Cr	₹55 L	-₹33 Cr	-₹26 Cr	-₹2 Cr	-₹15 Cr	-₹10 Cr	-₹25 Cr	-₹10 Cr	-₹3 Cr
₹21 Cr	-₹8 Cr	₹3 Cr	₹3 Cr	₹2 Cr	-₹38,000	₹35 L	-₹90 L	₹1 Cr	-₹32 L	-₹14 L	-₹7 Cr
₹2 Cr	₹10 Cr	₹6 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹50 L	₹1 Cr	₹42 L	₹74 L	₹88 L	₹7 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹34,000	₹0	₹0	₹0	₹0	₹0
₹2 Cr	₹22 L	₹38 L	₹49 L	₹36 L	-₹6 L	₹61 L	-₹7 L	₹0	₹0	₹0	₹0
₹25 Cr	₹2 Cr	₹10 Cr	₹6 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹50 L	₹1 Cr	₹42 L	₹74 L	₹88 L

Fundamental Ratios

Consolidated

Standalone

No results found

Zim Laboratories Share Price

144.76+4.46 (+3.18%)

+109.49% past 1 Year

Shareholding summary

Promoters

30.3%

FII

0.17%

DII

0.01%

1.18%

Others

68.34%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
30.30%	30.36%	30.35%	33.26%	33.26%	33.26%
0.17%	0.03%	0.00%	0.02%	0.00%	0.03%
0.01%	0.27%	0.00%	0.12%	0.16%	0.16%
1.18%	1.07%	0.00%	0.00%	0.00%	0.00%
68.34%	68.27%	69.65%	66.60%	66.58%	66.55%

Bulk & block deals

Name

Elimath Advisors Private Limited

Elizabeth Mathew

Ajit Ramkaran Sarda

Elimath Advisors Private Limited

Mathew Cyriac

Elizabeth Mathew

Yuga Stocks And Commodities Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
11 Nov 2025	Purchase	28.21 Cr	₹73.47	38.40 L	Bulk	7.879218	NSE
11 Nov 2025	Sell	28.20 Cr	₹73.45	38.40 L	Bulk	7.879218	NSE
29 Oct 2025	Purchase	2.17 Cr	₹81.58	2.65 L	Bulk	0.544739	NSE
29 Oct 2025	Sell	1.17 Cr	₹82.02	1.43 L	Bulk	0.293197	NSE
24 Oct 2025	Purchase	10.30 Cr	₹68.79	14.97 L	Bulk	3.071918	NSE
24 Oct 2025	Sell	10.80 Cr	₹68.84	15.69 L	Bulk	3.219399	NSE
17 Jul 2025	Purchase	20.69 Cr	₹115.31	17.94 L	Bulk	3.681072	NSE
17 Jul 2025	Sell	20.69 Cr	₹115.31	17.94 L	Bulk	3.681072	NSE
20 Mar 2025	Sell	4.46 Cr	₹93.51	4.77 L	Bulk	0.979405	NSE
20 Mar 2025	Purchase	41.75 L	₹99.73	41.86 K	Bulk	0.08589	NSE

Insider trading & SAST

Client name

Dr Anwar Daud

Mathew Cyriac & Pacs

Mathew Cyriac

Zakir Vali

Mathew Cyriac

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
29 Jul 2026	Other	Acquisition	0.15	—	—	80 K	11 Jun 2026	-	—	SAST	10(6)	—
14 Jul 2026	Promoter	Acquisition	0.15	—	—	80 K	11 Jun 2026	—	—	SAST	10(5)	—
12 May 2026	Other	Acquisition	7.5	19.34	—	40.13 L	13 Mar 2026	Market	1,03,48,766	SAST	29(2)	—
08 Mar 2025	Other	Disposal	1.83	13	—	8.89 L	10 Feb 2025	Market	63,36,064	SAST	29(2)	—
17 Oct 2024	Other	Acquisition	0.25	14.83	—	1.24 L	03 Sep 2024	Market	72,25,498	SAST	29(2)	—
10 Apr 2024	Other	Disposal	2.4	14.58	—	11.71 L	27 Mar 2024	Market	71,01,800	SAST	29(2)	—
13 Nov 2023	Other	Disposal	2.17	16.97	—	10.57 L	07 Nov 2023	Market	82,72,660	SAST	29(2)	—
09 Aug 2023	Other	Disposal	2.72	19.14	—	13.23 L	04 Aug 2023	Market	93,29,527	SAST	29(2)	—
27 Jun 2023	Other	Disposal	7.18	10.36	—	35 L	12 Jun 2023	Market	50,47,420	SAST	29(2)	—
29 Mar 2022	Other	Disposal	21.86	—	—	35.51 L	23 Mar 2022	Market	—	SAST	29(1)	—

Zim Laboratories Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Zim Laboratories Share Price

Zim Laboratories Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Zim Laboratories Share Price

Zim Laboratories Share Price

Oscillators

Moving averages

Zim Laboratories Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Zim Laboratories Share Price

Corporate Actions

Company details

Zim Laboratories Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Zim Laboratories Share Price

News

Zim Laboratories Q1 FY earnings show sharp EBITDA and margin compression

Zim Lab reports wider first quarter loss as revenue rises sharply

Zim Laboratories informs about newspaper advertisements

Zim Laboratories informs about newspaper publication

ZIM Laboratories secures marketing authorization for ‘Dabigatran Etexilate’ in Italy

Zim Laboratories - Quaterly Results

Zim Laboratories reports Profit after tax of 3.28 Crores, in the March 2026 quarter

Zim Laboratories reported sharp year-on-year decline in Q4 EBITDA and margin performance

Zim Laboratories Q4 FY earnings show softer profit and revenue performance YoY

Zim Laboratories informs about acquisition of equity shares of ZIMTAS

ZIM Laboratories invests Rs 89.45 lakh in ZIMTAS

Zim Laboratories informs about disclosure

Zim Laboratories informs about proceedings of EGM

Zim Laboratories gets nod to incorporate subsidiary in Chile

Zim Laboratories reports Profit after tax of 4.26 Crores, in the December 2025 quarter

Zim Laboratories informs about outcome of board meeting

Zim Laboratories Board Approves Issuance of Up to 47,64,497 Shares at Rs 73.46 to Florintree Trinex LLP.

Zim Laboratories informs about press release

ZIM Laboratories gets CDSCO’s approval for Naproxen plus Esomeprazole Capsules

Zim Laboratories informs about conference call

Zim Laboratories Ltd Share Price Today

Zim Laboratories Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator